PLUR
PLUR
NASDAQ · Biotechnology

Pluri Inc

$1.06
-0.01 (-0.93%)
As of Sep 22, 5:10 PM ET ·
Financial Highlights (FY 2026)
Revenue
803.4K
Net Income
-46,029,650
Gross Margin
98.8%
Profit Margin
-6,407.4%
Rev Growth
+131.9%
D/E Ratio
250.29
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 98.8% 48.9% 30.3% 30.3%
Operating Margin -6,796.9% -1,493.9% -1.4% -1.5%
Profit Margin -6,407.4% -1,605.8% -1.8% -1.4%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 803.4K 1.18M 4.21M 5.36M
Gross Profit 793.5K 575.4K 1.28M 1.62M
Operating Income -54,605,855 -17,559,971 -59,264 -77,809
Net Income -46,029,650 -17,884,542 -76,163 -75,826
Gross Margin 98.8% 48.9% 30.3% 30.3%
Operating Margin -6,796.9% -1,493.9% -1.4% -1.5%
Profit Margin -6,407.4% -1,605.8% -1.8% -1.4%
Rev Growth +131.9% +78.7% +17.4% +13.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 6.95M 12.36M 10.60M 10.10M
Total Equity 27.8K 49.4K 12.82M 11.60M
D/E Ratio 250.29 250.29 0.83 0.87
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -44,555,905 -17,808,595 -73,642 -95,229
Free Cash Flow -41,548 -57,067